Papers on prasugrel

8 papers

Friday, October 3

Research SquareOct 3

Memory deficits in hypertensive ApoE4 mice reversed by P2Y12 inhibition via different mechanisms in males and perimenopausal females

Preprint: experiments in miceAPOE

Monday, November 25

Drugs & AgingNov 25

Assessing Frailty-Specific Treatment Effect in Cardiovascular Disease: A Systematic Review

Systematic reviewCardiovascular disease

Tuesday, April 9

Journal of General Internal MedicineApr 9

Frailty as an Effect Modifier in Randomized Controlled Trials: A Systematic Review

Systematic review of randomized trialsInterventions

Sunday, September 24

Antioxidants & Redox SignalingSep 24

Aging and Antithrombotic Treatment

ReviewInterventions

Saturday, February 11

Clinical Research in CardiologyFeb 11

Implementation of the ESC STEMI guidelines in female and elderly patients over a 20-year period in a large German registry

Cohort study of 25,792 peoplePopulations

Saturday, October 14

The American Journal of CardiologyOct 14

Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)

Study in peopleInterventions

Wednesday, April 19

Clinical Drug InvestigationApr 19

Evaluation of the Pharmacokinetics and Pharmacodynamics of Prasugrel in Japanese Elderly Subjects

Trial in peopleInterventions

Thursday, May 12

Journal of Thrombosis and ThrombolysisMay 12

Prasugrel 5 mg inhibits platelet P-selectin and GPIIb-IIIa expression in very elderly and non elderly: results from the GENERATIONS trial, a pharmacodynamic study in stable CAD patients

Randomized trial in 23 peopleInterventions